Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

A new study has made the case for synching your daily calories with your own circadian rhythm to improve glucose metabolism, ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

The advice to “eat less, move more” isn’t just outdated, it’s harmful. Obesity is a chronic condition shaped by biology, ...

Obesity isn’t just a global problem - it’s hitting Singapore hard. In 2022, nearly 12 out of every 100 adults were obese - ...

Racial disparities in childhood obesity have risen due to social determinants, food insecurity, and systemic barriers, ...

Understanding the link between obesity, fatty liver disease and kidney stones provides a new perspective on prevention and ...